PubRank

Coen A Stegeman

Author PubWeight™ 86.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012 6.93
2 Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007 6.13
3 Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2004 3.63
4 Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am J Transplant 2005 2.46
5 Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis 2013 2.41
6 High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007 2.01
7 Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest 2013 1.99
8 Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2006 1.87
9 Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007 1.86
10 Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 2006 1.85
11 Protective role of endothelial nitric oxide synthase. J Pathol 2003 1.73
12 Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum 2004 1.70
13 Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 2004 1.69
14 Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2007 1.44
15 Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2002 1.41
16 Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008 1.37
17 Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 2003 1.31
18 Kidney injury molecule-1 in renal disease. J Pathol 2010 1.27
19 IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol 2010 1.24
20 Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum 2002 1.18
21 Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2001 1.13
22 Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum 2005 1.10
23 Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 2013 1.08
24 Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003 1.03
25 Review article: The role of CD4(+) T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 2009 1.03
26 Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol 2007 1.03
27 Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009 1.01
28 Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 2006 0.98
29 Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods 2003 0.97
30 Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford) 2010 0.97
31 Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis. PLoS One 2011 0.94
32 Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Nephrology (Carlton) 2008 0.92
33 Utility of an intraoperative gamma probe in the surgical management of secondary or tertiary hyperparathyroidism. Am J Surg 2008 0.91
34 CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann N Y Acad Sci 2007 0.90
35 Higher body mass index is associated with higher fractional creatinine excretion in healthy subjects. Nephrol Dial Transplant 2011 0.90
36 Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis. Nephrol Dial Transplant 2005 0.89
37 Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2004 0.88
38 -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis. Clin Immunol 2002 0.88
39 Is serum HMGB1 a biomarker in ANCA-associated vasculitis? Arthritis Res Ther 2013 0.88
40 HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis. Rheumatology (Oxford) 2009 0.88
41 Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo. Ann Rheum Dis 2010 0.87
42 Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure. Nitric Oxide 2003 0.87
43 High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells. Transplantation 2003 0.87
44 Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology. J Clin Immunol 2003 0.86
45 Use of mycophenolic acid in non-transplant renal diseases. Nephrol Dial Transplant 2007 0.85
46 Pulmonary: renal syndrome with a focus on anti-GBM disease. Semin Respir Crit Care Med 2011 0.85
47 New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev 2002 0.83
48 Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration. Arthritis Res Ther 2011 0.83
49 Autoantibodies vex the vasculature. Nat Med 2008 0.82
50 Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis. J Rheumatol 2007 0.82
51 Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future? Kidney Int Suppl 2004 0.81
52 Determinants of renal potassium excretion in critically ill patients: the role of insulin therapy. Crit Care Med 2012 0.81
53 ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 2004 0.81
54 Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis. Ann Rheum Dis 2009 0.80
55 Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA). Arthritis Res Ther 2013 0.80
56 Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis. PLoS One 2011 0.80
57 Genetics of ANCA-associated vasculitides. Cleve Clin J Med 2002 0.79
58 Oleic acid loading does not add to the nephrotoxic effect of albumin in an amphibian and chronic rat model of kidney injury. Nephrol Dial Transplant 2008 0.79
59 A difficult diagnosis. Lancet 2004 0.79
60 Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls. Ann Rheum Dis 2007 0.78
61 The renal angiopoietin/Tie2 system in lethal human sepsis. Crit Care 2014 0.78
62 Pauci-immune necrotizing glomerulonephritis. Rheum Dis Clin North Am 2010 0.78
63 Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. Nephrol Dial Transplant 2004 0.78
64 Patients with Wegener's granulomatosis: a long-term follow-up study. Clin Exp Rheumatol 2010 0.78
65 Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression. J Clin Apher 2014 0.77
66 Expression of inducible and endothelial nitric oxide synthases, formation of peroxynitrite and reactive oxygen species in human chronic renal transplant failure. Am J Transplant 2002 0.77
67 RAS blockade in experimental renal transplantation. Benefits and limitations. Curr Drug Targets Cardiovasc Haematol Disord 2003 0.77
68 Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis. Am J Clin Pathol 2003 0.76
69 Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2002 0.75
70 Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty? J Rheumatol 2005 0.75
71 Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life? Arthritis Res Ther 2013 0.75
72 [Serious sequelae of hypothermia in cryoglobulinaemia]. Ned Tijdschr Geneeskd 2009 0.75
73 [Guideline 'Diagnostics of small-vessel vasculitis']. Ned Tijdschr Geneeskd 2012 0.75
74 A false-positive antineutrophil cytoplasmic antibody proteinase 3 test in a patient with pulmonary-renal syndrome. J Rheumatol 2014 0.75
75 [From 'malignancy' to IgG4-related systemic disease]. Ned Tijdschr Geneeskd 2011 0.75